4.6 Article

The angiotensin-calcineurin-NFAT pathway mediates stretch-induced up-regulation of matrix metalloproteinases-2/-9 in atrial myocytes

Journal

BASIC RESEARCH IN CARDIOLOGY
Volume 104, Issue 4, Pages 435-448

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s00395-008-0772-6

Keywords

mechanical stretch; atrial fibrillation; calcineurin; matrix metalloproteinases

Funding

  1. Deutsche Forschungsgemeinschaft (DFG) [Lu 869/4-1]
  2. IZKF Biomat

Ask authors/readers for more resources

During atrial fibrillation, arterial hypertension and systolic or diastolic heart failure, atrial myocytes are exposed to increased baseline stretch. Atrial stretch has been shown to induce cellular hypertrophy and extracellular matrix remodeling (ECM) via angiotensin-II dependent pathways and the matrix metalloproteinases system (MMPs). We hypothesized that atrial myocytes exposed to static stretch may increase their ECM remodeling activity via up-regulation of MMP-2/-9. We then tested the hypothesis that the membrane bound angiotensin-II type 1 (AT1) receptor and the intracellular calcineurin (Cn)-NFAT signaling pathway are potential mediators of stretch-induced MMP alterations, since Cn-NFAT is one important contributor to myocyte hypertrophy. Neonatal rat atrial myocytes (NRAM) were cultured under conditions of static stretch by 21%. The differential effects of selective AT1 receptor blockade by losartan, Cn blockade by Cyclosporine-A (CsA) or NFAT inhibition by 11R-VIVIT (VIV), were analyzed. Stretch resulted in a significant up-regulation of active-MMP-2/-9 protein amount (active-MMP-2 ng/A mu g: control 8.95 +/- A 0.64 vs. stretch 13.11 +/- A 0.74 / active-MMP-9 ng/A mu g: control 1.45 +/- A 0.18 vs. stretch 1.94 +/- A 0.21, all n = 5) and enzyme activity (MMP-2 in %: control 1 +/- A 0.0 vs. stretch 1.87 +/- A 0.25, n = 7) associated with a significant increase of the membrane-type-1-MMP (MT1-MMP) protein expression (MT1-MMP in %: control 1 +/- A 0.0 vs. stretch 2.17 +/- A 0.21, n = 8). These observations were accompanied by an activation of the Cn-NFAT pathway (Cn-activity in nmol PO4 release/20 A mu g protein/30 min: control 0.37 +/- A 0.08 vs. stretch 0.65 +/- A 0.09, n = 3 / NFATc1-DNA binding activity in %: control 1 +/- A 0.0 vs. stretch 1.53 +/- A 0.17, n = 3). Losartan, CsA or VIV abolished stretch-induced alterations in MMP-2/-9 and MT1-MMP expression and enzyme activity by normalizing the Cn-activity and the DNA binding activity of NFATc1. Our results present new insights in molecular mechanisms of ECM remodeling activity of atrial myocytes exposed to static stretch. The AT1-Cn-NFAT pathway is a potential mediator of MMP activation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Medicine, General & Internal

Immunotherapy and cardiovascular diseases: novel avenues for immunotherapeutic approaches

C. A. Bonfiglio, C. Weber, D. Atzler, E. Lutgens

Summary: Current therapies for cardiovascular disease primarily focus on lipid lowering and face residual risk. Inflammation, along with lipids, plays a significant role in atherosclerosis. Clinical trials targeting the interleukin-1 beta-inflammasome pathway have successfully reduced cardiovascular events but not overall CVD mortality. Novel and improved immunotherapeutics for CVD are eagerly anticipated.

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2023)

Article Cardiac & Cardiovascular Systems

Properties and fate of human mesenchymal stem cells upon miRNA let-7f-promoted recruitment to atherosclerotic plaques

Virginia Egea, Remco Theodorus Adrianus Megens, Donato Santovito, Sarawuth Wantha, Richard Brandl, Wolfgang Siess, Sajjad Khani, Oliver Soehnlein, Alexander Bartelt, Christian Weber, Christian Ries

Summary: let-7f promotes hMSC tropism towards atheromas through the LL-37/FPR2 axis and demonstrates that hMSCs develop a potentially athero-protective signature upon contact with the human plaque environment.

CARDIOVASCULAR RESEARCH (2023)

Article Cardiac & Cardiovascular Systems

Myeloid CD40 deficiency reduces atherosclerosis by impairing macrophages' transition into a pro-inflammatory state

Laura A. Bosmans, Claudia M. van Tiel, Suzanne A. B. M. Aarts, Lisa Willemsen, Jeroen Baardman, Bram W. van Os, Myrthe den Toom, Linda Beckers, David J. Ahern, Johannes H. M. Levels, Aldo Jongejan, Perry D. Moerland, Sanne G. S. Verberk, Jan van den Bossche, Menno M. P. J. de Winther, Christian Weber, Dorothee Atzler, Claudia Monaco, Norbert Gerdes, Annelie Shami, Esther Lutgens

Summary: This study investigates the role of CD40 in atherosclerosis and shows that inhibiting CD40 signaling can reduce atherosclerosis. The researchers used myeloid-specific CD40-deficient mice and found that the absence of CD40 in myeloid cells reduces atherosclerosis and systemic inflammation by preventing pro-inflammatory macrophage polarization.

CARDIOVASCULAR RESEARCH (2023)

Article Cardiac & Cardiovascular Systems

Flow-mediated dilation reference values for evaluation of endothelial function and cardiovascular health

Christian Heiss, Ana Rodriguez-Mateos, Mariam Bapir, Simon S. Skene, Helmut Sies, Malte Kelm

Summary: This study aims to assess Flow-Mediated Dilation (FMD) values in healthy individuals and provides reference values for cardiovascular health measurement. The study found that FMD values are inversely correlated with age, body mass index (BMI), glucose, cholesterol, and blood pressure. Individuals with higher FMD values are younger and have smaller brachial artery diameter, lower blood pressure and cholesterol. Comparisons with coronary artery disease (CAD) patients also showed that FMD values can be used to exclude cardiovascular disease and determine the health status. The meta-analysis results showed that the average FMD in healthy individuals is 6.4%, with a decline trend associated with age.

CARDIOVASCULAR RESEARCH (2023)

Article Hematology

Thrombosis and Haemostasis 2022 Editors' Choice Papers

Christian Weber, Xavier Blanchet, Gregory Y. H. Lip

THROMBOSIS AND HAEMOSTASIS (2023)

Editorial Material Hematology

A Happy New Year 2023 from Thrombosis and Haemostasis

Gregory Y. H. Lip, Anne Rigby, Christian Weber

THROMBOSIS AND HAEMOSTASIS (2023)

Review Cell Biology

Neuroimmune cardiovascular interfaces in atherosclerosis

Sarajo K. Mohanta, Changjun Yin, Christian Weber, Andreas J. R. Habenicht

Summary: Two pairs of biological systems, namely the nervous and vascular systems, and the nervous and immune systems, have been defined as major participants in the regulation of physiological and pathological tissue reactions. The interactions between these systems have led to the concepts of neurovascular link and neuroimmunology. Recent studies on atherosclerosis have proposed the concept of neuroimmune cardiovascular interfaces (NICIs), which involve complex crosstalks between the nervous system, immune system, and cardiovascular system.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Endothelial ADAM10 controls cellular response to oxLDL and its deficiency exacerbates atherosclerosis with intraplaque hemorrhage and neovascularization in mice

Emiel P. C. van der Vorst, Sanne L. Maas, Kosta Theodorou, Linsey J. F. Peters, Han Jin, Timo Rademakers, Marion J. Gijbels, Mat Rousch, Yvonne Jansen, Christian Weber, Michael Lehrke, Corinna Lebherz, Daniela Yildiz, Andreas Ludwig, Jacob F. Bentzon, Erik A. L. Biessen, Marjo M. P. C. Donners

Summary: This study demonstrates that endothelial ADAM10 plays a protective role in the development of murine atherosclerosis, primarily by limiting inflammation induced by oxidized low-density lipoprotein (oxLDL). The findings provide novel opportunities for treating atherosclerosis progression, but caution should be exercised when considering the use of ADAM10 inhibitors for therapy in other diseases.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2023)

Article Biochemistry & Molecular Biology

A structural model of the iRhom-ADAM17 sheddase complex reveals functional insights into its trafficking and activity

Selcan Kahveci-Tuerkoez, Katharina Blaesius, Justyna Wozniak, Cindy Rinkens, Anke Seifert, Petr Kasparek, Henrike Ohm, Shixin Oltzen, Martin Nieszporek, Nicole Schwarz, Aaron Babendreyer, Christian Preisinger, Radislav Sedlacek, Andreas Ludwig, Stefan Duesterhoeft

Summary: The structure-function relationship of the iRhom-ADAM17 complex is poorly understood. Using AI-based modelling, the researchers identified different regions in the iRhom homology domain (IRHD) that contribute differently to iRhom functions. Through various experiments, the predicted structure-function determinants were validated, and the regulatory role of IRHD in the cohesion and forward trafficking of the iRhom-ADAM17 complex was demonstrated. Overall, this study provides mechanistic insights into the shedding event mediated by iRhom-ADAM17, which is crucial for multiple cytokine and growth factor pathways.

CELLULAR AND MOLECULAR LIFE SCIENCES (2023)

Article Materials Science, Biomaterials

Bioprinting-associated pulsatile hydrostatic pressure elicits a mild proinflammatory response in epi- and endothelial cells

Ramin Nasehi, Jana Schieren, Caroline Grannemann, Alena L. Palkowitz, Aaron Babendreyer, Nicole Schwarz, Sanja Aveic, Andreas Ludwig, Rudolf E. Leube, Horst Fischer

Summary: The modality of hydrostatic pressure during nozzle-based bioprinting affects the biological response of processed cells differently. Pulsatile hydrostatic pressure leads to an immediate increase of intracellular ATP in both endothelial and epithelial cells. Bioprinting-associated hydrostatic pressure triggers a pro-inflammatory response in endothelial cells but not in epithelial cells.

BIOMATERIALS ADVANCES (2023)

Editorial Material Cardiac & Cardiovascular Systems

Coronary Endarterectomy in Combination With Coronary Artery Bypass Grafting-Stepping Into the Light?

Tobias Zeus, Artur Lichtenberg, Malte Kelm

AMERICAN JOURNAL OF CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease

Stephan Sachs, Anna Goetz, Brian Finan, Annette Feuchtinger, Richard D. DiMarchi, Yvonne Doering, Christian Weber, Matthias H. Tschoep, Timo D. Mueller, Susanna M. Hofmann

Summary: Long-acting acylated GIP analog (acyl-GIP) treatment can improve dyslipidemia and atherosclerosis independently of body weight loss. This treatment may improve dyslipidemia by directly modulating lipid metabolism in the inguinal fat depot.

CARDIOVASCULAR DIABETOLOGY (2023)

Article Cell Biology

Tissue Inhibitor of Metalloproteinases-1 Interacts with CD74 to Promote AKT Signaling, Monocyte Recruitment Responses, and Vascular Smooth Muscle Cell Proliferation

Simon Ebert, Lan Zang, Noor Ismail, Michael Otabil, Adrian Frohlich, Virginia Egea, Susann Acs, Mikkel Hoeberg, Marie-Luise Berres, Christian Weber, Jose M. A. Moreira, Christian Ries, Juergen Bernhagen, Omar El Bounkari

Summary: TIMP-1 interacts with CD74 to regulate vascular inflammation and atherosclerosis. TIMP-1 binding to CD74 promotes monocyte migration and vascular smooth muscle cell proliferation, playing a crucial role in vascular inflammation and atherosclerosis.

CELLS (2023)

Article Cell Biology

The Impact of the Nervous System on Arteries and the Heart: The Neuroimmune Cardiovascular Circuit Hypothesis

Sarajo K. Mohanta, Ting Sun, Shu Lu, Zhihua Wang, Xi Zhang, Changjun Yin, Christian Weber, Andreas J. R. Habenicht

Summary: The nervous, immune, and cardiovascular systems form a tissue network that regulate cardiovascular function. The different systems interact with each other, and further research may lead to new therapies for cardiovascular diseases.

CELLS (2023)

Editorial Material Cardiac & Cardiovascular Systems

Dynamic mitral regurgitation caused by exercise-induced left bundle branch abnormality and unmasked by isometric handgrip testing

Maximilian Spieker, Malte Kelm, Verena Veulemans

EUROPEAN HEART JOURNAL-CASE REPORTS (2023)

No Data Available